Zuprevo 180 mg/ml is licensed for the treatment and prevention of bovine respiratory disease (BRD) associated with M. haemolytica, P. multocida and H.somni sensitive to tildipirosin.
Zuprevo contains the active tildipirosin - a 16-membered tribasic macrolide antibiotic unique to MSD Animal Health.
